Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Federal funding opportunity RFA-CA-27-002 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.